Crossmark

The Clinical Utility of Dual Energy Computed Tomography Quantitative Parameters in Evaluating Immunohistochemical (IHC) Biomarkers - Estrogen Receptor (ER), Progesterone Receptor (PR) And HER 2 (Herceptin 2 Receptor) in Invasive Breast Cancer: A Prospective Study

Crossref DOI link: https://doi.org/10.1007/s40944-026-01111-7

Published Online: 2026-02-23

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Eswaran, Kiruthika https://orcid.org/0009-0002-8682-0175
Gantait, Shubhamoy https://orcid.org/0009-0006-6802-166X
Barathi, Deepak

Maroju, Nanda Kishore

Badhe, Bhawana
License Information

Text and Data Mining valid from 2026-02-23

Version of Record valid from 2026-02-23
More Information

Article History

Received: 30 November 2025

Revised: 9 February 2026

Accepted: 15 February 2026

First Online: 23 February 2026

Declarations

:

: Approval was obtained from the ethics committee of the institute where the study was done. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.

: The authors declare no conflict of interest with respect to the research, authorship, and/or publication of this article.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below